KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Edwards Lifesciences (EW) Leases (2019 - 2025)

Edwards Lifesciences (EW) has 7 years of Leases data on record, last reported at $102.7 million in Q4 2025.

  • For Q4 2025, Leases rose 4.58% year-over-year to $102.7 million; the TTM value through Dec 2025 reached $102.7 million, up 4.58%, while the annual FY2025 figure was $102.7 million, 4.58% up from the prior year.
  • Leases reached $102.7 million in Q4 2025 per EW's latest filing, up from $96.5 million in the prior quarter.
  • Across five years, Leases topped out at $104.4 million in Q3 2024 and bottomed at $84.2 million in Q2 2022.
  • Average Leases over 5 years is $92.1 million, with a median of $91.5 million recorded in 2021.
  • Peak YoY movement for Leases: increased 17.22% in 2021, then fell 8.56% in 2023.
  • A 5-year view of Leases shows it stood at $92.1 million in 2021, then rose by 0.22% to $92.3 million in 2022, then dropped by 8.56% to $84.4 million in 2023, then increased by 16.35% to $98.2 million in 2024, then grew by 4.58% to $102.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $102.7 million in Q4 2025, $96.5 million in Q3 2025, and $99.0 million in Q2 2025.